RECOMMENDED PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | _747412-49-3.png) |
| NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc | ||||
| 51902 | AT13148 | 1056901-62-2 | ≧98% |  |
| AT13148, a first-in-class multi-AGC kinase inhibitor, against gastric cancer cells. A | ||||
| 51603 | AZD6482 | 1173900-33-8 | ≧98.0% |  |
| AZD6482 is aPI3Kinhibitor withIC50of 10 nM, 8-, 87- and 109-fold more selective to PI | ||||
| 51905 | CPI-613(Devimistat ) | 95809-78-2 | ≧98.0% |  |
| CPI-613( Devimistat ) is an E1 pyruvate dehydrogenase (PDH) modulator that prevents c | ||||
| 52023 | DCC-2036(Rebastinib) | 1020172-07-9 | 98% | _1020172-07-9.png) |
| Rebastinib(DCC-2036;DCC2036) is an inhibitor of tyrosine kinases TIE2 and ABL1.Rebast | ||||
| 52019 | GSK 2656157 | 1337532-29-2 | 98% |  |
| GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9 | ||||
| 51608 | SSR128129E | 848318-25-2 | 98% |  |
| SSR128129E is an orally-active and allostericFGFR1inhibitor withIC50of 1.9 M, while n | ||||
| 51607 | VE-822 ( Berzosertib ) | 1232416-25-9 | ≧98.0% | _1232416-25-9.png) |
| VE-822(Berzosertib), an analogue of VE-821 with increased potency and selectivity aga | ||||
| 52003 | Zosuquidar trihydrochloride | 167465-36-3 | 99% | _167465-36-3.png) |
| zosuquidar trihydrochloride is adifluorocyclopropyl quinoline. Zosuquidar trihydrochl | ||||
| 52105 | SNS-032 ( BMS-387032 ) | 345627-80-7 | 98% | _345627-80-7.png) |
| SNS-032 has firstly been described as a selective inhibitor ofCDK2withIC50of 48 nM an | ||||
| 51614 | AMG-925 | 1401033-86-0 | 98% |  |
| AMG925, Bulk in stock, contact us by email for detailed quotation.AMG-925 is a potent | ||||
| 52026 | AMG-319 | 1608125-21-8 | 98% |  |
| AMG 319 is an investigational, highly selective, small molecule inhibitor of PI3K tha | ||||